Over the Counter

Pharmacists navigate ACIP changes, legal battles, and shifting vaccine schedules reshaping US immunization policy and respiratory season planning.

The pharmacy benefits industry is undergoing a massive restructuring, driven by a wave of government action designed to shift focus back to the patient.

Despite significant progress made in the US opioid epidemic, systemic change is necessary to move pain management forward across health care.

In a technologically advanced health care landscape, solutions to address language barriers are necessary and can be the difference between life and death for complex medication regimens.

As the pharmacist’s role continues to expand throughout health care, they are now being challenged to step in as opioid stewards in a rapidly evolving pain management landscape.

With the Medicare GLP-1 Bridge Program just 2 weeks old, a drug market expert shared their thoughts on what the initiative may mean for pharmacists and their patients.

Often operating in the shadows, LTC pharmacy is the backbone of medication management for aging and immunocompromised patients.

With the dual issue of pharmacy deserts and caregiver shortages across the US, technology is filling a much-needed gap for rural patient populations.

Learn about how this functional medicine pharmacist’s personal journey led her to addressing patients’ root causes for disease through exploring gut health dysregulation.

As clinical roles expand, the need for robust pharmacy infrastructure to streamline workflows and ensure medication access has never been more critical.

In an evolving health care landscape bringing all providers into a primary care team, diabetes is no different and the pharmacist community can offer so much for patients.

In a health care landscape of silos and fragmentation, especially in the menopause space, pharmacists have increasingly provided their efforts to better care coordination for their communities.

From PBM reform and AI to burnout and closures, Tom DePietro, PharmD, addresses the current state of independent pharmacy.

As diabetes rises to be one of the most prominent chronic diseases globally, pharmacists have reached out as key resources for preventing and managing its complications.

With value-based care initiatives on the rise in the US health care system, one partnership in Ohio is showing early signs of significant success.

Amid shifting vaccine recommendations and an evolving health care landscape, pharmacists continue to weather the storm as frontline community immunizers.

In an evolving pharmacy landscape, accreditation can be difficult to manage, which is why experts like Mitch Lamb, PharmD, can steer businesses onto their desired paths.

With a 7-year target date, the FDA is moving away from 10-digit NDCs and toward a universal 12-digit format.

With workforce and work-life balance issues plaguing pharmacy, the newly introduced hybrid pharmacist role is creating innovation across the greater pharmacy industry.

With a slew of new GLP-1 indications approved in recent history, researchers and experts are now diving into their use in treating substance use disorders.

Amid recent comments from FDA Commissioner Marty Makary, MD, MPH, that “everything should be OTC,” Mark Garofoli, PharmD, BCGP, CPE, CTTS, helps pharmacists understand what lies ahead.

In a bonus episode of the Over the Counter podcast, William A. Bryson, PharmD, joined to help celebrate Diabetes Alert Day—recognized annually on the fourth Tuesday in March.

With ongoing concerns about the safety and formulation of compounded GLP-1s, Annie Lambert, PharmD, BCSCP, added her expert insights into the recent crackdown of these products.

With drug shortages continuing to disrupt patient care and pharmacy operations, Lani Bertrand breaks down how AI and automation are reshaping the way pharmacies respond to supply chain disruptions.

With a key exemption under DSCSA expiring at the end of the year, Matt Sample from Cencora helps pharmacies understand the tools and processes they need now to best comply with the law.

With patients and pharmacists existing in new territories since the COVID-19 pandemic, at-home diagnostic testing has come a long way in improving the potential for convenient access to care.

With the federal government continuing its reconsideration of vaccine guidelines in the US, Jeff Goad, PharmD, MPH, explains what it means for community pharmacies.

As the pharmacy industry seemingly transforms in real-time, expert pharmacists and digital health experts explain how DTP models are paving a new path for drug distribution.